Daclatasvir/ Sofosbuvir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Daclatasvir 60 mg + Sofosbuvir 400 mg
Reference Brands: -
Category: Hepatitis
Daclatasvir and Sofosbuvir tablets are a potent oral antiviral combination for treating chronic Hepatitis C infection. This fixed-dose therapy targets multiple HCV genotypes by inhibiting viral replication enzymes. Manufactured under EU-GMP and USFDA standards, it is widely used in B2B supply, hospital tenders, and global markets with full regulatory support for quick registration.
Manufacture or export Daclatasvir/ Sofosbuvir? List it or send an offer →
Product Description:
Daclatasvir and Sofosbuvir Tablets are an oral, fixed-dose combination used to treat chronic Hepatitis C infection across multiple genotypes. Daclatasvir is an NS5A inhibitor, and Sofosbuvir is an NS5B polymerase inhibitor; together, they provide a highly effective, well-tolerated antiviral regimen. Available as 60 mg Daclatasvir and 400 mg Sofosbuvir tablets, manufactured under EU-GMP and USFDA standards. Ideal for B2B licensing, hospital tenders, and global distribution with full CTD dossiers for fast registration in regulated markets.
Daclatasvir/ Sofosbuvir — third party manufacturing & bulk supply
Daclatasvir/ Sofosbuvir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Daclatasvir/ Sofosbuvir is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Daclatasvir/ Sofosbuvir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Daclatasvir/ Sofosbuvir →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Daclatasvir + Sofosbuvir is used for the treatment of chronic hepatitis C virus (HCV) infection, mainly genotypes 1, 3, and others as per clinical requirement. It helps reduce viral load and supports complete viral clearance when taken as a combination therapy.
It is made from the active ingredients daclatasvir, an NS5A inhibitor, and sofosbuvir, an NS5B polymerase inhibitor. Together they block viral replication and prevent the hepatitis C virus from multiplying.
Common trade names include Daklinza (daclatasvir) and Sovaldi (sofosbuvir) when sold separately. Combined generic formulations are available in India and other regions under several brand names.
Daklinza (daclatasvir) is made by Bristol-Myers Squibb, and Sovaldi (sofosbuvir) is made by Gilead Sciences. Combination generics are produced by multiple licensed manufacturers in India and other countries.
The generic name is daclatasvir + sofosbuvir.
Brand names include Daklinza (daclatasvir), Sovaldi (sofosbuvir), and various combined generic brands depending on the region.
It is manufactured by Bristol-Myers Squibb and Gilead Sciences, along with licensed generic manufacturers in India and several other global regions.
Related Products
Human Normal Immunoglobulin
Strength:
IVIG: 5%, 10%, 16%, 20%; SCIG: 20%
Form: (IVIG) & (SCIG)
Reference Brands: -
View Details
Interferon Alfa-2b
Strength:
3 million IU/vial, 5 million IU/vial, 10 million IU/vial
Form: Lyophilized Powder for Injection
Reference Brands: Intron A® (EU & US)
View Details
Peginterferon Alfa Injection
Strength:
120 mcg, 150 mcg, 180 mcg
Form: Injection
Reference Brands: Pegasys® (US & EU), PegIntron® (EU)
View Details
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit
